MX353411B - Composiciones farmacéuticas que contienen ácido hialurónico para usarlas en el tratamiento de la enfermedad del disco negro. - Google Patents

Composiciones farmacéuticas que contienen ácido hialurónico para usarlas en el tratamiento de la enfermedad del disco negro.

Info

Publication number
MX353411B
MX353411B MX2015014868A MX2015014868A MX353411B MX 353411 B MX353411 B MX 353411B MX 2015014868 A MX2015014868 A MX 2015014868A MX 2015014868 A MX2015014868 A MX 2015014868A MX 353411 B MX353411 B MX 353411B
Authority
MX
Mexico
Prior art keywords
treatment
hyaluronic acid
pharmaceutical compositions
compositions containing
containing hyaluronic
Prior art date
Application number
MX2015014868A
Other languages
English (en)
Other versions
MX2015014868A (es
Inventor
Nicola Giordan
Pierangelo Bellato
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of MX2015014868A publication Critical patent/MX2015014868A/es
Publication of MX353411B publication Critical patent/MX353411B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)

Abstract

La presente invención describe y reclama composiciones farmacéuticas en forma de hidrogel para usarlas en el tratamiento de la degeneración de los discos intervertebrales, en particular las formas de deshidratación y vaciado del nucleus pulposus conocidas como "enfermedad del disco negro"; estas composiciones comprenden un derivado de ácido hialurónico que forma hidrogeles con características reológicas precisas que los hacen ideales para rellenar el nucleus pulposus.
MX2015014868A 2013-04-24 2014-04-23 Composiciones farmacéuticas que contienen ácido hialurónico para usarlas en el tratamiento de la enfermedad del disco negro. MX353411B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000110A ITPD20130110A1 (it) 2013-04-24 2013-04-24 Composizioni farmaceutiche comprendenti acido ialuronico per il trattamento del black disc
PCT/IB2014/060928 WO2014174450A1 (en) 2013-04-24 2014-04-23 Pharmaceutical compositions containing hyaluronic acid for use in the treatment of black disk disease

Publications (2)

Publication Number Publication Date
MX2015014868A MX2015014868A (es) 2016-03-09
MX353411B true MX353411B (es) 2018-01-10

Family

ID=48579315

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014868A MX353411B (es) 2013-04-24 2014-04-23 Composiciones farmacéuticas que contienen ácido hialurónico para usarlas en el tratamiento de la enfermedad del disco negro.

Country Status (16)

Country Link
US (1) US10064887B2 (es)
EP (1) EP2988792B1 (es)
CN (1) CN105188785B (es)
CA (1) CA2910104C (es)
CY (1) CY1119065T1 (es)
DK (1) DK2988792T3 (es)
EA (1) EA028443B1 (es)
ES (1) ES2638659T3 (es)
HK (1) HK1219063A1 (es)
IT (1) ITPD20130110A1 (es)
LT (1) LT2988792T (es)
MX (1) MX353411B (es)
PT (1) PT2988792T (es)
SA (1) SA515370029B1 (es)
SI (1) SI2988792T1 (es)
WO (1) WO2014174450A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201616849D0 (en) * 2016-10-04 2016-11-16 Nat Univ Ireland Regneration of diseased intervertebral discs
CN118126415A (zh) * 2017-09-19 2024-06-04 香港科技大学 生物可相容材料以及用于制备和使用所述生物可相容材料的方法
IT202100032111A1 (it) 2021-12-22 2023-06-22 Fidia Farm Spa Nuovi sostituti biocompatibili dell’umor vitreo

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138572B1 (en) 1983-10-11 1990-07-25 FIDIA S.p.A. Hyaluronic acid fractions having pharmaceutical activity, methods for preparation thereof, and pharmaceutical compositions containing the same
IT1263393B (it) 1993-07-30 1996-08-05 Fidia Advanced Biopolymers Srl Processo per la preparazione e purificazione di acido ialuronico ad alto peso molecolare
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
US8357147B2 (en) * 2005-08-17 2013-01-22 Spinal Restoration, Inc. Method for repairing intervertebral discs
US20080075657A1 (en) * 2006-04-18 2008-03-27 Abrahams John M Biopolymer system for tissue sealing
CN101285052B (zh) * 2008-04-29 2010-06-30 中国人民解放军第三军医大学第二附属医院 一种应用于组织工程椎间盘髓核构建的种子细胞接种方法
IT1394570B1 (it) * 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
IT1395392B1 (it) * 2009-08-27 2012-09-14 Fidia Farmaceutici Geli viscoelastici come nuovi filler
IT1402384B1 (it) 2010-09-09 2013-09-04 Fidia Farmaceutici Processo per la produzione di acido ialuronico in escherichia coli o bacillus megaterium
IT1402385B1 (it) 2010-09-09 2013-09-04 Fidia Farmaceutici Processo per la produzione di acido ialuronico in escherichia coli o bacillus subtilis
CN101954123A (zh) * 2010-10-21 2011-01-26 中国人民解放军第三军医大学第二附属医院 一种人工椎间盘复合体组织及其制备方法

Also Published As

Publication number Publication date
PT2988792T (pt) 2017-08-30
CN105188785B (zh) 2017-11-17
EA028443B1 (ru) 2017-11-30
EP2988792B1 (en) 2017-05-31
EP2988792A1 (en) 2016-03-02
MX2015014868A (es) 2016-03-09
WO2014174450A1 (en) 2014-10-30
US20160067274A1 (en) 2016-03-10
CA2910104C (en) 2021-06-08
CA2910104A1 (en) 2014-10-30
LT2988792T (lt) 2017-08-25
SA515370029B1 (ar) 2018-04-29
ITPD20130110A1 (it) 2014-10-25
CY1119065T1 (el) 2018-01-10
ES2638659T3 (es) 2017-10-23
DK2988792T3 (en) 2017-07-31
CN105188785A (zh) 2015-12-23
HK1219063A1 (zh) 2017-03-24
EA201591859A1 (ru) 2016-04-29
US10064887B2 (en) 2018-09-04
SI2988792T1 (sl) 2017-09-29

Similar Documents

Publication Publication Date Title
WO2016004068A8 (en) Hydrogel compositions comprising encapsulated cells and methods of use thereof
EP3166487A4 (en) Bone reconstruction and orthopedic implants
EP3102145A4 (en) Dental implant for bone collection and distribution
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
EP3310336A4 (en) Storage stable compositions and methods for the treatment of refractive errors of the eye
MX2016016756A (es) Terapia con células madre en patologías endometriales.
EP3452075A4 (en) OPHTHALMIC PHARMACEUTICAL COMPOSITION
EP3434291A4 (en) COMPOSITION FOR THE TREATMENT OF BELTS
IL275435A (en) TATK – CDKL5 fusion proteins, preparations, formulations, and their uses
EP3531898A4 (en) IMPLANT FOR BONE RECONSTRUCTION
EP3100635A4 (en) Compact container incorporating rod-shaped cosmetic container
PH12017500348A1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
MX2015014868A (es) Composiciones farmaceuticas que contienen acido hialuronico para usarlas en el tratamiento de la enfermedad del disco negro.
EP3031465A4 (en) Pharmaceutical composition for promoting bone tissue formation, containing stauntonia hexaphylla leaf extract as active ingredient
EP3324956A4 (en) ENANTIOMERS OF TETRAHYDRO-N, N-DIMETHYL-2,2-DIPHENYL-3-FURANMETHANAMINE (ANAVEX2-73) AND USE THEREOF IN THE TREATMENT OF MORBUS ALZHEIMER AND OTHER FAILURES MODULATED BY THE SIGMA-1 RECEPTOR
EP2978428A4 (en) STABLE NANO COMPOSITION WITH EPIRUBICIN, PROCESS FOR THE PRODUCTION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
EP2978421A4 (en) STABLE NANOCOMPOSITION COMPRISING DOCATEXEL, PROCESS FOR PREPARATION THEREOF, USE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
EP3285819A4 (en) Cornea mimetic biomaterials: vitrified collagen-cyclodextrin implants
MX2016012050A (es) Una composicion para el uso en el tratamiento de dolor relacionado con discos intervertebrales.
IL252221B (en) Transformed aromatic compounds and pharmaceutical preparations for self-repair and tissue reconstruction
MX2018003081A (es) Una composicion para uso en el tratamiento del dolor relacionado con los discos intervertebrales.
EP3145514A4 (en) Formulation for regeneration of bone, cartilage, teeth, and periodontium and treatment of tumors and cysts
EP3496636A4 (en) INTERVERTEBRAL DISC REPLACEMENT
AU2016904443A0 (en) Bone reconstruction implant
GB201616935D0 (en) Intervertebral disc prosthesis

Legal Events

Date Code Title Description
FG Grant or registration